Endoscopy 2005; 37(1): 42-47
DOI: 10.1055/s-2004-826083
State of the Art
© Georg Thieme Verlag KG Stuttgart · New York

Inflammatory Bowel Disease

H.  Herfarth1 , G.  Rogler1
  • 1 Dept. of Internal Medicine I, University of Regensburg, Regensburg, Germany
Further Information

Publication History

Publication Date:
19 January 2005 (online)

This review summarizes important publications that have appeared during the last year dealing with imaging techniques and endoscopy, as well as the management of low-grade dysplasia and stenosis in inflammatory bowel disease. Magnetic resonance enteroclysis and capsule endoscopy are currently emerging as new imaging techniques for the small bowel in Crohn’s disease. While magnetic resonance enteroclysis is, at least in Europe, increasingly being used as a reference method, the value of capsule endoscopy for the management of inflammatory bowel disease is still being evaluated. Chromoendoscopy is being studied in patients with long-lasting ulcerative colitis and may be a promising and sensitive technique for the diagnosis of dysplasia. However, there are conflicting data regarding the appropriate management when low-grade dysplasia is diagnosed in patients with ulcerative colitis. Endoscopic dilation can often be successfully carried out in cases of intestinal stenosis. The results of long-term follow-up studies indicate that several dilation procedures are often necessary and that a relatively high percentage of patients still have to undergo surgery.

References

  • 1 Parente F, Greco S, Molteni M. et al . Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel.  Aliment Pharmacol Ther. 2003;  18 1009-1016
  • 2 Rapaccini G L, Pompili M, Orefice R. et al . Contrast-enhanced power Doppler of the intestinal wall in the evaluation of patients with Crohn disease.  Scand J Gastroenterol. 2004;  39 188-194
  • 3 Schreyer A G, Geissler A, Albrich H. et al . Abdominal MRI after enteroclysis or with oral contrast in patients with suspected or proven Crohn’s disease.  Clin Gastroenterol Hepatol. 2004;  2 491-497
  • 4 Wold P B, Fletcher J G, Johnson C D. et al . Assessment of small bowel Crohn disease: noninvasive peroral CT enterography compared with other imaging methods and endoscopy: feasibility study.  Radiology. 2003;  229 275-281
  • 5 Gourtsoyiannis N, Papanikolaou N, Grammatikakis J. et al . Assessment of Crohn’s disease activity in the small bowel with MR and conventional enteroclysis: preliminary results.  Eur Radiol. 2004;  14 1017-1024
  • 6 Madsen S M, Thomsen H S, Schlichting P. et al . Evaluation of treatment response in active Crohn’s disease by low-field magnetic resonance imaging.  Abdom Imaging. 1999;  24 232-239
  • 7 Narin B, Ajaj W, Gohde S. et al . Combined small and large bowel MR imaging in patients with Crohn’s disease: a feasibility study.  Eur Radiol. 2004;  14 1535-1542
  • 8 Debatin J F, Lauenstein T C. Virtual magnetic resonance colonography.  Gut. 2003;  52 (Suppl) 17-22
  • 9 Schreyer A G, Golder S, Seitz J. et al . New diagnostic avenues in inflammatory bowel diseases: capsule endoscopy, magnetic resonance imaging and virtual enteroscopy.  Dig Dis. 2003;  21 129-137
  • 10 Fireman Z, Mahajna E, Broide E. et al . Diagnosing small bowel Crohn’s disease with wireless capsule endoscopy.  Gut. 2003;  52 390-392
  • 11 Eliakim R, Fischer D, Suissa A. et al . Wireless capsule video endoscopy is a superior diagnostic tool in comparison to barium follow-through and computerized tomography in patients with suspected Crohn’s disease.  Eur J Gastroenterol Hepatol. 2003;  15 363-367
  • 12 Voderholzer W A, Ortner M, Rogalla P. et al . Diagnostic yield of wireless capsule enteroscopy in comparison with computed tomography enteroclysis.  Endoscopy. 2003;  35 1009-1014
  • 13 Mow W S, Lo S K, Targan S R. et al . Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease: diagnostic yield of wireless capsule enteroscopy in comparison with computed tomography enteroclysis.  Clin Gastroenterol Hepatol. 2004;  2 31-40
  • 14 Lo S K. Capsule endoscopy in the diagnosis and management of inflammatory bowel disease.  Gastrointest Endosc Clin N Am. 2004;  14 179-193
  • 15 Modigliani R. Endoscopic severity index for Crohn’s disease [letter].  Gastrointest Endosc. 1990;  36 637
  • 16 Modigliani R, Mary J Y, Simon J F. et al . Clinical, biological, and endoscopic picture of attacks of Crohn’s disease. Evolution on prednisolone. Groupe d’Etude Thérapeutique des Affections Inflammatoires Digestives.  Gastroenterology. 1990;  98 811-818
  • 17 McLeod R S, Wolff B G, Steinhart A H. et al . Risk and significance of endoscopic/radiological evidence of recurrent Crohn’s disease.  Gastroenterology. 1997;  113 1823-1827
  • 18 Rutgeerts P. Modern therapy for inflammatory bowel disease.  Scand J Gastroenterol Suppl. 2003;  237 30-33
  • 19 Kiesslich R, Fritsch J, Holtmann M. et al . Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis.  Gastroenterology. 2003;  124 880-888
  • 20 Rutter M D, Saunders B P, Schofield G. et al . Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis.  Gut. 2004;  53 256-260
  • 21 Ajaj W, Pelster G, Treichel U. et al . Dark lumen magnetic resonance colonography: comparison with conventional colonoscopy for the detection of colorectal pathology.  Gut. 2003;  52 1738-1743
  • 22 Schreyer A G, Rath H C, Kikinis R. et al . A comparison of MRI colonography with conventional colonoscopy for the assessment of intestinal inflammation in patients with inflammatory bowel disease: a feasibility study.  Gut. 2004;  in press
  • 23 Itzkowitz S H, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases.  Gastroenterology. 2004;  126 1634-1648
  • 24 Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease.  Aliment Pharmacol Ther. 2003;  18 1-5
  • 25 Rutter M, Saunders B, Wilkinson K. et al . Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.  Gastroenterology. 2004;  126 451-459
  • 26 Bernstein C, Shanahan F, Weinstein W M. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?.  Lancet. 1994;  343 71-74
  • 27 Ullman T, Croog V, Harpaz N. et al . Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis.  Gastroenterology. 2003;  125 1311-1319
  • 28 Lim C H, Dixon M F, Vail A. et al . Ten year follow up of ulcerative colitis patients with and without low grade dysplasia.  Gut. 2003;  52 1127-1132
  • 29 Lynch D A, Lobo A J, Sobala G M. et al . Failure of colonoscopic surveillance in ulcerative colitis.  Gut. 1993;  34 1075-1080
  • 30 Connell W R, Lennard-Jones J E, Williams C B. et al . Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.  Gastroenterology. 1994;  107 934-944
  • 31 Eaden J, Abrams K, McKay H. et al . Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis.  J Pathol. 2001;  194 152-157
  • 32 Eaden J A, Ward B A, Mayberry J F. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance.  Gastrointest Endosc. 2000;  51 123-128
  • 33 Hanauer S B. Surveying surveillance: are gastroenterologists consistently inconsistent, inconsistently consistent, or poorly educated?.  Gastrointest Endosc. 2000;  51 240-242
  • 34 Befrits R, Ljung T, Jaramillo E. et al . Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study.  Dis Colon Rectum. 2002;  45 615-620
  • 35 Bernstein C N, Weinstein W M, Levine D S. et al . Physicians’ perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis.  Am J Gastroenterol. 1995;  90 2106-2114
  • 36 Ullman T A, Loftus E V , Kakar S. et al . The fate of low grade dysplasia in ulcerative colitis.  Am J Gastroenterol. 2002;  97 922-927
  • 37 Sabate J M, Villarejo J, Bouhnik Y. et al . Hydrostatic balloon dilatation of Crohn’s strictures.  Aliment Pharmacol Ther. 2003;  18 409-413
  • 38 Morini S, Hassan C, Lorenzetti R. et al . Long-term outcome of endoscopic pneumatic dilatation in Crohn’s disease.  Dig Liver Dis. 2003;  35 893-897
  • 39 Thomas-Gibson S, Brooker J C, Hayward C M. et al . Colonoscopic balloon dilation of Crohn’s strictures: a review of long-term outcomes.  Eur J Gastroenterol Hepatol. 2003;  15 485-488
  • 40 Loftus E V . Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences.  Gastroenterology. 2004;  126 1504-1517
  • 41 Brooker J C, Beckett C G, Saunders B P. et al . Long-acting steroid injection after endoscopic dilation of anastomotic Crohn’s strictures may improve the outcome: a retrospective case series.  Endoscopy. 2003;  35 333-337
  • 42 Holzknecht N, Helmberger T, von Ritter C. et al . MRI of the small intestine with rapid MRI sequences in Crohn disease after enteroclysis with oral iron particles.  Radiologe. 1998;  38 29-36
  • 43 Schunk K, Kern A, Heussel C P. et al . Hydro-MRT with fast sequences in Crohn’s disease: a comparison with fractionated gastrointestinal passage.  Röfo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr. 1999;  170 338-346
  • 44 Aschoff A J, Zeitler H, Merkle E M. et al . MR enteroclysis for nuclear spin tomographic diagnosis of inflammatory bowel diseases with contrast enhancement.  Röfo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr. 1997;  167 387-391
  • 45 Rieber A, Wruk D, Nussle K. et al . MRI of the abdomen combined with enteroclysis in Crohn disease using oral and intravenous Gd-DTPA.  Radiologe. 1998;  38 23-28

H. Herfarth, M. D.

Klinik und Poliklinik für Innere Medizin I

Universität Regensburg · 93042 Regensburg · Germany

Fax: +49-941-944-7179

Email: Hans.Herfarth@klinik.uni-regensburg.de

    >